Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study. - Kircik LH; Alonso-Llamazares J; Bhatia N; Bukhalo M; Devani AR; Draelos ZD; DuBois J; Gooderham MJ; Kempers SE; Lain E; Lee M; Moore A; et al. (The British journal of dermatology, 2023)